b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">30168128</PMID>\n        <DateCompleted>\n            <Year>2019</Year>\n            <Month>12</Month>\n            <Day>19</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2019</Year>\n            <Month>12</Month>\n            <Day>19</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1096-9896</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>247</Volume>\n                    <Issue>1</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>01</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>The Journal of pathology</Title>\n                <ISOAbbreviation>J. Pathol.</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Integrated eicosanoid lipidomics and gene expression reveal decreased prostaglandin catabolism and increased 5-lipoxygenase expression in aggressive subtypes of endometrial cancer.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>21-34</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1002/path.5160</ELocationID>\n            <Abstract>\n                <AbstractText>Eicosanoids comprise a diverse group of bioactive lipids which orchestrate inflammation, immunity, and tissue homeostasis, and whose dysregulation has been implicated in carcinogenesis. Among the various eicosanoid metabolic pathways, studies of their role in endometrial cancer (EC) have very much been confined to the COX-2 pathway. This study aimed to determine changes in epithelial eicosanoid metabolic gene expression in endometrial carcinogenesis; to integrate these with eicosanoid profiles in matched clinical specimens; and, finally, to investigate the prognostic value of candidate eicosanoid metabolic enzymes. Eicosanoids and related mediators were profiled using liquid chromatography-tandem mass spectrometry in fresh frozen normal, hyperplastic, and cancerous (types I and II) endometrial specimens (n\xe2\x80\x89=\xe2\x80\x89192). Sample-matched epithelia were isolated by laser capture microdissection and whole genome expression analysis was performed using microarrays. Integration of eicosanoid and gene expression data showed that the accepted paradigm of increased COX-2-mediated prostaglandin production does not apply in EC carcinogenesis. Instead, there was evidence for decreased PGE<sub>2</sub> /PGF<sub>2\xce\xb1</sub> inactivation via 15-hydroxyprostaglandin dehydrogenase (HPGD) in type II ECs. Increased expression of 5-lipoxygenase (ALOX5) mRNA was also identified in type II ECs, together with proportional increases in its product, 5-hydroxyeicosatetraenoic acid (5-HETE). Decreased HPGD and elevated ALOX5 mRNA expression were associated with adverse outcome, which was confirmed by immunohistochemical tissue microarray analysis of an independent series of EC specimens (n\xe2\x80\x89=\xe2\x80\x89419). While neither COX-1 nor COX-2 protein expression had prognostic value, low HPGD combined with high ALOX5 expression was associated with the worst overall and progression-free survival. These findings highlight HPGD and ALOX5 as potential therapeutic targets in aggressive EC subtypes. Copyright \xc2\xa9 2018 Pathological Society of Great Britain and Ireland. Published by John Wiley &amp; Sons, Ltd.</AbstractText>\n                <CopyrightInformation>Copyright \xc2\xa9 2018 Pathological Society of Great Britain and Ireland. Published by John Wiley &amp; Sons, Ltd.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Cummings</LastName>\n                    <ForeName>Michele</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pathology and Tumour Biology, Leeds Institute of Cancer &amp; Pathology, St James\'s University Hospital, Leeds, UK.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Massey</LastName>\n                    <ForeName>Karen A</ForeName>\n                    <Initials>KA</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>School of Pharmacy and Centre for Skin Sciences, Bradford School of Pharmacy, School of Life Sciences, University of Bradford, Bradford, UK.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Mappa</LastName>\n                    <ForeName>Georgia</ForeName>\n                    <Initials>G</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pathology and Tumour Biology, Leeds Institute of Cancer &amp; Pathology, St James\'s University Hospital, Leeds, UK.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Wilkinson</LastName>\n                    <ForeName>Nafisa</ForeName>\n                    <Initials>N</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Cellular Pathology, University College London Hospital NHS Trust, London, UK.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Hutson</LastName>\n                    <ForeName>Richard</ForeName>\n                    <Initials>R</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Gynaecological Oncology, St James\'s Institute of Oncology, St James\'s University Hospital, Leeds, UK.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Munot</LastName>\n                    <ForeName>Sarika</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Gynaecological Oncology, St James\'s Institute of Oncology, St James\'s University Hospital, Leeds, UK.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Saidi</LastName>\n                    <ForeName>Sam</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Obstetrics and Gynaecology, Central Clinical School, University of Sydney, Camperdown, Australia.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Nugent</LastName>\n                    <ForeName>David</ForeName>\n                    <Initials>D</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Gynaecological Oncology, St James\'s Institute of Oncology, St James\'s University Hospital, Leeds, UK.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Broadhead</LastName>\n                    <ForeName>Timothy</ForeName>\n                    <Initials>T</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Gynaecological Oncology, St James\'s Institute of Oncology, St James\'s University Hospital, Leeds, UK.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Wright</LastName>\n                    <ForeName>Alexander I</ForeName>\n                    <Initials>AI</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pathology and Tumour Biology, Leeds Institute of Cancer &amp; Pathology, St James\'s University Hospital, Leeds, UK.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Barber</LastName>\n                    <ForeName>Stuart</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Statistics, University of Leeds, Leeds, UK.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Nicolaou</LastName>\n                    <ForeName>Anna</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Laboratory for Lipidomics and Lipid Biology, Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Orsi</LastName>\n                    <ForeName>Nicolas M</ForeName>\n                    <Initials>NM</Initials>\n                    <Identifier Source="ORCID">0000-0003-0890-0399</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pathology and Tumour Biology, Leeds Institute of Cancer &amp; Pathology, St James\'s University Hospital, Leeds, UK.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <GrantList CompleteYN="Y">\n                <Grant>\n                    <GrantID>1090</GrantID>\n                    <Agency>Pathological Society of Great Britain and Ireland Career Development Fellowship</Agency>\n                    <Country>International</Country>\n                </Grant>\n                <Grant>\n                    <GrantID>LPP053</GrantID>\n                    <Acronym>YCR_</Acronym>\n                    <Agency>Yorkshire Cancer Research</Agency>\n                    <Country>United Kingdom</Country>\n                </Grant>\n                <Grant>\n                    <Agency>National Institute for Health Research</Agency>\n                    <Country>International</Country>\n                </Grant>\n                <Grant>\n                    <Agency>Pathological Society of Great Britain and Ireland</Agency>\n                    <Country>International</Country>\n                </Grant>\n                <Grant>\n                    <Acronym>YCR_</Acronym>\n                    <Agency>Yorkshire Cancer Research</Agency>\n                    <Country>United Kingdom</Country>\n                </Grant>\n                <Grant>\n                    <GrantID>RG1210</GrantID>\n                    <Agency>Wellbeing of Women</Agency>\n                    <Country>International</Country>\n                </Grant>\n            </GrantList>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D013485">Research Support, Non-U.S. Gov\'t</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2018</Year>\n                <Month>11</Month>\n                <Day>27</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>England</Country>\n            <MedlineTA>J Pathol</MedlineTA>\n            <NlmUniqueID>0204634</NlmUniqueID>\n            <ISSNLinking>0022-3417</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D015777">Eicosanoids</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 1.1.1.-</RegistryNumber>\n                <NameOfSubstance UI="D006911">Hydroxyprostaglandin Dehydrogenases</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 1.1.1.141</RegistryNumber>\n                <NameOfSubstance UI="C035859">15-hydroxyprostaglandin dehydrogenase</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 1.13.11.34</RegistryNumber>\n                <NameOfSubstance UI="D001094">Arachidonate 5-Lipoxygenase</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 1.3.11.34</RegistryNumber>\n                <NameOfSubstance UI="C583212">ALOX5 protein, human</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D001094" MajorTopicYN="N">Arachidonate 5-Lipoxygenase</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D018269" MajorTopicYN="N">Carcinoma, Endometrioid</DescriptorName>\n                <QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>\n                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>\n                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>\n                <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002851" MajorTopicYN="N">Chromatography, High Pressure Liquid</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015777" MajorTopicYN="N">Eicosanoids</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016889" MajorTopicYN="N">Endometrial Neoplasms</DescriptorName>\n                <QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>\n                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>\n                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>\n                <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D004847" MajorTopicYN="N">Epithelial Cells</DescriptorName>\n                <QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>\n                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName>\n                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015971" MajorTopicYN="N">Gene Expression Regulation, Enzymologic</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015972" MajorTopicYN="N">Gene Expression Regulation, Neoplastic</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006911" MajorTopicYN="N">Hydroxyprostaglandin Dehydrogenases</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D055432" MajorTopicYN="N">Metabolomics</DescriptorName>\n                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D020411" MajorTopicYN="N">Oligonucleotide Array Sequence Analysis</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000077982" MajorTopicYN="N">Progression-Free Survival</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D053719" MajorTopicYN="N">Tandem Mass Spectrometry</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="Y">15-PGDH</Keyword>\n            <Keyword MajorTopicYN="Y">15-hydroxyprostaglandin dehydrogenase</Keyword>\n            <Keyword MajorTopicYN="Y">5-lipoxygenase</Keyword>\n            <Keyword MajorTopicYN="Y">COX</Keyword>\n            <Keyword MajorTopicYN="Y">LOX</Keyword>\n            <Keyword MajorTopicYN="Y">cyclooxygenase</Keyword>\n            <Keyword MajorTopicYN="Y">eicosanoids</Keyword>\n            <Keyword MajorTopicYN="Y">endometrial cancer</Keyword>\n            <Keyword MajorTopicYN="Y">endometrium</Keyword>\n            <Keyword MajorTopicYN="Y">gene expression</Keyword>\n            <Keyword MajorTopicYN="Y">lipidomics</Keyword>\n            <Keyword MajorTopicYN="Y">prognostic</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2018</Year>\n                <Month>05</Month>\n                <Day>08</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2018</Year>\n                <Month>07</Month>\n                <Day>30</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2018</Year>\n                <Month>08</Month>\n                <Day>26</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>9</Month>\n                <Day>1</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>12</Month>\n                <Day>20</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>9</Month>\n                <Day>1</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">30168128</ArticleId>\n            <ArticleId IdType="doi">10.1002/path.5160</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'